QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=E65F5FF2579828E3957F6EC0659BC027;jsessionid=F3F7D600406B02DD75B6184B178BF327;jsessionid=734B308E25BB1D0BF012D5904D21F53D;jsessionid=AA46DBBE4EFBB950F5EB0E10747DF686;jsessionid=9CEC94CDB634449CAA4BC1B7306D641C (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
4. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
5. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=E65F5FF2579828E3957F6EC0659BC027;jsessionid=F3F7D600406B02DD75B6184B178BF327;jsessionid=734B308E25BB1D0BF012D5904D21F53D;jsessionid=AA46DBBE4EFBB950F5EB0E10747DF686;jsessionid=9CEC94CDB634449CAA4BC1B7306D641C